A Study Of Community-Informed Interventions In Congestive Heart Failure Management

Overview

About this study

The purpose of this study is to expand subject matter expertise and sustained capacity for equity-oriented care within the Advanced Care Ecosystem (ACE) by engaging patients, caregivers, CHWs, and care-team stakeholders in development work focused on adults living with congestive CHF and adverse social determinants of health (SDoH).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Aim 1

    • Patients living with CHF:

      • Age 18 years or older.

      • Diagnosis or clinical documentation of CHF or heart failure in the Mayo Clinic medical record.

      • Empaneled in Mayo Clinic, Rochester, primary care

      • Evidence in the EHR of one or more adverse SDoH, elevated utilization, medical/social complexity.

      • Able to provide informed consent.

      • Able to participate in study procedures.

    • Caregivers:

      • Age 18 years or older.

      • Caregiver with relevant lived, caregiving, or community experience related to CHF, and nominated by the patient.

      • Able to provide informed consent

      • Able to participate in study procedures.

  • Aim 2

    • CHW and care-team stakeholders:

      • Age 18 years or older.

      • Current or recent role relevant to CHF care, transitions of care, SDoH, patient education, or CHW workflows.

      • Able to provide informed consent

      • Able to participate in study procedures.

Exclusion Criteria:

  • Under age 18 years.

  • Unable or unwilling to provide informed consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 05/18/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Contact us for the latest status

Rochester, Minn.

Mayo Clinic principal investigator

Majken Wingo, M.D.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions